Background The added value of antiphosphatidylserine/prothrombin antibodies (aPS/PT) in
the diagnostic workup of antiphospholipid syndrome (APS) is unclear. Currently, diagnosis …

Objectives Anti-β2 glycoprotein I domain I (anti-domain I) and anti-phosphatidylserine/
prothrombin (aPS/PT) antibodies are present in patients with antiphospholipid syndrome …

Background Diagnosis of antiphospholipid syndrome (APS) requires persistent presence of
lupus anticoagulant (LAC), anticardiolipin (aCL) IgG/IgM, or anti‐β2 glycoprotein I (aβ2GPI) …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence
of antiphospholipid antibodies (aPLs), which can lead to thrombosis and pregnancy …

The updated international consensus criteria for definite antiphospholipid syndrome (APS)
are useful for scientific clinical studies. However, there remains a need for diagnostic criteria …

Objective. To determine the prevalence and clinical association of anti‐phosphatidylserine/
prothrombin antibodies (aPS/PT) in patients with a history of pregnancy complications …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by thrombosis
and/or pregnancy-related morbidity accompanied by persistently positive antiphospholipid …

Background: Antiphosphatidylserine/prothrombin complex (aPS/PT) antibodies are
emerging as an important marker for antiphospholipid syndrome (APS). We aimed to …

BACKGROUND: To clarify the association and diagnostic utility of measuring
antiphosphatidyl serine (aPS), antiprothrombin (aPT) and the antiphosphatidyl …

Background: The aim of the study was to determine the prevalence and clinical associations
of antiphosphatidylserine/prothrombin antibodies (aPS/PT) with thrombosis and pregnancy …